NCT03375294View on ClinicalTrials.gov

Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

April 5, 2020

Conditions
Post Traumatic Stress Disorder
Interventions
DRUG

Nitrous Oxide

One hour inhalation of 50% nitrous oxide, an odorless, colorless gas FDA approved as an induction agent for dental sedation

Trial Locations (1)

94304

Veterans Affairs Palo Alto, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT03375294 - Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD) | Biotech Hunter | Biotech Hunter